Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal

Vyne Therapeutics entered an exchange agreement to issue pre-funded warrants for 133,290 common shares in exchange for 133,290 common shares.

• Pre-funded warrants are immediately exercisable at an exercise price of $0.0001 per share.
• Warrants cap exercise to avoid beneficial ownership above 9.99%, adjustable up to 19.99% with 61 days’ notice.
• The exchange closed July 29, 2026; 2,669,788 common shares were outstanding, and pre-funded warrants were outstanding for 25,914,530 common shares.